Rapid developments in the healthcare and drug discovery sector are leading to the introduction of new therapeutic solutions for the treatment of neurological diseases. Authorities such as the World Health Organization, the National Institute of Neurological Disorders and Stroke, and the National Institutes of Health are taking constructive steps to encourage research activities and find a remedy for neurological disease treatment. The National Institute of Neurological Disorders and Stroke (NINDS) biomarkers program is focused on enhancing the quality and efficiency of neurotherapeutic clinical research and supports the biomarkers validation. The program promotes rigorous biomarker identification and validation by providing funds for research activities.
https://www.theinsightpartners.com/assets/images/other/report-deliverables-img1.webp
Source:https://www.theinsightpartners.com/
